Breaking News Instant updates and real-time market news.

CNK

Cinemark

$9.01 /

-0.065 (-0.72%)

09:39
11/09/20
11/09
09:39
11/09/20
09:39

Cinemark upgraded to Outperform from Market Perform at Barrington

Barrington analyst James Goss upgraded Cinemark to Outperform from Market Perform with a $15 price target.

CNK Cinemark
$9.01 /

-0.065 (-0.72%)

10/26/20
Fly Intel: Top five analyst downgrades
10/26/20 Barrington
Cinemark downgraded to Market Perform from Outperform at Barrington
10/12/20 B. Riley Securities
Cinemark price target lowered to $11 from $14 at B. Riley Securities
10/05/20 Loop Capital
Cinemark price target lowered to $16 from $18 at Loop Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Genmab will not advance development of enapotamab vedotin after POC data » 10:44
11/24/20
11/24
10:44
11/24/20
10:44
GMAB

Genmab

$35.46 /

-0.62 (-1.72%)

Genmab A/S announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GMAB Genmab
$35.46 /

-0.62 (-1.72%)

GMAB Genmab
$35.46 /

-0.62 (-1.72%)

11/16/20 UBS
Genmab price target raised to DKK 2,680 from DKK 2,540 at UBS
11/05/20 H.C. Wainwright
Genmab price target raised to $45 from $42 at H.C. Wainwright
10/27/20 Goldman Sachs
Genmab price target raised to DKK 2,320 from DKK 1,112 at Goldman Sachs
09/23/20 H.C. Wainwright
Genmab price target raised to $42 from $41 at H.C. Wainwright
GMAB Genmab
$35.46 /

-0.62 (-1.72%)

GMAB Genmab
$35.46 /

-0.62 (-1.72%)

Hot Stocks
Bristol-Myers Squibb CVR rallies as FDA resumes domestic inspections » 10:43
11/24/20
11/24
10:43
11/24/20
10:43
BMY-R

Bristol-Myers Squibb CVR

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$62.80 /

+0.88 (+1.42%)

FDA Commissioner Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY-R Bristol-Myers Squibb CVR
$0.00 /

+ (+0.00%)

BMY Bristol-Myers
$62.80 /

+0.88 (+1.42%)

BMY-R Bristol-Myers Squibb CVR
$0.00 /

+ (+0.00%)

11/23/20 BofA
BofA upgrades Schrodinger to Buy after 'major' collaboration announcement
11/17/20 Mizuho
Bristol-Myers Squibb CVR price target lowered to $3.34 from $6.17 at Mizuho
11/16/20 Societe Generale
Bristol-Myers upgraded to Buy from Hold at Societe Generale
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein
BMY Bristol-Myers
$62.80 /

+0.88 (+1.42%)

11/23/20 BofA
BofA upgrades Schrodinger to Buy after 'major' collaboration announcement
11/17/20 Mizuho
Bristol-Myers Squibb CVR price target lowered to $3.34 from $6.17 at Mizuho
11/16/20 Societe Generale
Bristol-Myers upgraded to Buy from Hold at Societe Generale
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein
BMY-R Bristol-Myers Squibb CVR
$0.00 /

+ (+0.00%)

BMY Bristol-Myers
$62.80 /

+0.88 (+1.42%)

BMY-R Bristol-Myers Squibb CVR
$0.00 /

+ (+0.00%)

BMY Bristol-Myers
$62.80 /

+0.88 (+1.42%)

BMY-R Bristol-Myers Squibb CVR
$0.00 /

+ (+0.00%)

BMY Bristol-Myers
$62.80 /

+0.88 (+1.42%)

BMY-R Bristol-Myers Squibb CVR
$0.00 /

+ (+0.00%)

BMY Bristol-Myers
$62.80 /

+0.88 (+1.42%)

Hot Stocks
Genmab says enapotamab vedotin expansion cohorts data didn't meet POC criteria  10:42
11/24/20
11/24
10:42
11/24/20
10:42
GMAB

Genmab

$35.46 /

-0.62 (-1.72%)

 
ShowHide Related Items >><<
GMAB Genmab
$35.46 /

-0.62 (-1.72%)

GMAB Genmab
$35.46 /

-0.62 (-1.72%)

11/16/20 UBS
Genmab price target raised to DKK 2,680 from DKK 2,540 at UBS
11/05/20 H.C. Wainwright
Genmab price target raised to $45 from $42 at H.C. Wainwright
10/27/20 Goldman Sachs
Genmab price target raised to DKK 2,320 from DKK 1,112 at Goldman Sachs
09/23/20 H.C. Wainwright
Genmab price target raised to $42 from $41 at H.C. Wainwright
GMAB Genmab
$35.46 /

-0.62 (-1.72%)

GMAB Genmab
$35.46 /

-0.62 (-1.72%)

Hot Stocks
Genmab says will not advance development of enapotamab vedotin  10:41
11/24/20
11/24
10:41
11/24/20
10:41
GMAB

Genmab

$35.46 /

-0.62 (-1.72%)

 
ShowHide Related Items >><<
GMAB Genmab
$35.46 /

-0.62 (-1.72%)

GMAB Genmab
$35.46 /

-0.62 (-1.72%)

11/16/20 UBS
Genmab price target raised to DKK 2,680 from DKK 2,540 at UBS
11/05/20 H.C. Wainwright
Genmab price target raised to $45 from $42 at H.C. Wainwright
10/27/20 Goldman Sachs
Genmab price target raised to DKK 2,320 from DKK 1,112 at Goldman Sachs
09/23/20 H.C. Wainwright
Genmab price target raised to $42 from $41 at H.C. Wainwright
GMAB Genmab
$35.46 /

-0.62 (-1.72%)

GMAB Genmab
$35.46 /

-0.62 (-1.72%)

General news
Oil Action: WTI crude » 10:40
11/24/20
11/24
10:40
11/24/20
10:40

Oil Action: WTI crude has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Syndicate
Ozon indicated to open at $39, IPO priced at $30 » 10:32
11/24/20
11/24
10:32
11/24/20
10:32
OZON

Ozon

$0.00 /

+ (+0.00%)

Ozon (OZON) priced 33M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 24
    Nov
Conference/Events
The Wall Street Journal holds WSJ Newsmakers live virtual event » 10:30
11/24/20
11/24
10:30
11/24/20
10:30

The Wall Street…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Treasury Action: the rally's on in equities and the surge in risk appetite is weighing on Treasuries » 10:30
11/24/20
11/24
10:30
11/24/20
10:30

Treasury Action: the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Piper reiterates Overweight rating on Alnylam after Oxlumo approved » 10:27
11/24/20
11/24
10:27
11/24/20
10:27
ALNY

Alnylam

$126.70 /

+3.715 (+3.02%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALNY Alnylam
$126.70 /

+3.715 (+3.02%)

ALNY Alnylam
$126.70 /

+3.715 (+3.02%)

09/30/20 Berenberg
Alnylam reinitiated with a Hold at Berenberg
09/08/20 Citi
Alnylam initiated with a Buy at Citi
08/11/20 Oppenheimer
Alnylam downgraded to Perform on valuation at Oppenheimer
08/11/20 Oppenheimer
Alnylam downgraded to Perform from Outperform at Oppenheimer
ALNY Alnylam
$126.70 /

+3.715 (+3.02%)

ALNY Alnylam
$126.70 /

+3.715 (+3.02%)

Options
Bank of America call volume above normal and directionally bullish » 10:25
11/24/20
11/24
10:25
11/24/20
10:25
BAC

Bank of America

$28.40 /

+1 (+3.65%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAC Bank of America
$28.40 /

+1 (+3.65%)

BAC Bank of America
$28.40 /

+1 (+3.65%)

10/06/20 JPMorgan
Bank of America price target raised to $27.50 from $26 at JPMorgan
09/03/20 Deutsche Bank
Bank of America upgraded to Buy from Hold at Deutsche Bank
07/09/20 DA Davidson
Bank of America downgraded to Neutral from Buy at DA Davidson
07/08/20
Fly Intel: Top five analyst initiations
BAC Bank of America
$28.40 /

+1 (+3.65%)

BAC Bank of America
$28.40 /

+1 (+3.65%)

BAC Bank of America
$28.40 /

+1 (+3.65%)

BAC Bank of America
$28.40 /

+1 (+3.65%)

Conference/Events
UBS technology analyst to hold an analyst/industry conference call » 10:25
11/24/20
11/24
10:25
11/24/20
10:25

Technology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Morgan Stanley healthcare analysts to hold analyst/industry conference call » 10:25
11/24/20
11/24
10:25
11/24/20
10:25

Healthcare Distribution…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
10X Capital Venture Acquisition opens at $10, IPO priced at $10 per unit » 10:22
11/24/20
11/24
10:22
11/24/20
10:22
VCVC

10X Capital Venture Acquisition

$0.00 /

+ (+0.00%)

10X Capital Venture…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Syndicate
Tiga Acquisition opens for trade at $10.20, IPO priced at $10 » 10:20
11/24/20
11/24
10:20
11/24/20
10:20
TINV

Tiga Acquisition

$0.00 /

+ (+0.00%)

Tiga Acquisition priced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
The Bank of Finland to hold a webinar » 10:17
11/24/20
11/24
10:17
11/24/20
10:17

Federal Reserve Bank of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Technical Analysis
NASDAQ market internals summary » 10:17
11/24/20
11/24
10:17
11/24/20
10:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Periodicals
General Electric warns of additional job cuts in aviation unit, WSJ reports » 10:16
11/24/20
11/24
10:16
11/24/20
10:16
GE

General Electric

$10.70 /

+0.625 (+6.20%)

General Electric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GE General Electric
$10.70 /

+0.625 (+6.20%)

GE General Electric
$10.70 /

+0.625 (+6.20%)

09:56 Today
Fly Intel: Top five analyst upgrades
07:30 Today Oppenheimer
Oppenheimer upgrades GE to Outperform, sees Culp's turnaround gaining traction
06:08 Today Oppenheimer
General Electric upgraded to Outperform from Perform at Oppenheimer
11/13/20 Barclays
General Electric price target raised to $11 from $9 at Barclays
GE General Electric
$10.70 /

+0.625 (+6.20%)

GE General Electric
$10.70 /

+0.625 (+6.20%)

GE General Electric
$10.70 /

+0.625 (+6.20%)

GE General Electric
$10.70 /

+0.625 (+6.20%)

Technical Analysis
NYSE market internals summary » 10:16
11/24/20
11/24
10:16
11/24/20
10:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Periodicals
Nvidia to support AMD mobility CPUs for high-end GPUs, WccfTech reports » 10:15
11/24/20
11/24
10:15
11/24/20
10:15
AMD

AMD

$84.00 /

-1.31 (-1.54%)

, NVDA

Nvidia

$520.03 /

-5.42 (-1.03%)

Nvidia's (NVDA) RTX…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMD AMD
$84.00 /

-1.31 (-1.54%)

NVDA Nvidia
$520.03 /

-5.42 (-1.03%)

AMD AMD
$84.00 /

-1.31 (-1.54%)

11/23/20 RBC Capital
AMD price target raised to $100 from $92 at RBC Capital
11/23/20 Mizuho
Micron price target raised to $70 from $56 at Mizuho
11/16/20 Cleveland Research
AMD upgraded to Buy on improved market share outlook at Cleveland Research
11/16/20 Cleveland Research
AMD upgraded to Buy from Neutral at Cleveland Research
NVDA Nvidia
$520.03 /

-5.42 (-1.03%)

11/19/20 Truist
Nvidia price target raised to $643 from $623 at Truist
11/19/20 New Street
New Street keeps $400 target on Nvidia, says cycles will peak soon
11/19/20 Craig-Hallum
Nvidia price target raised to $520 from $500 at Craig-Hallum
11/19/20 Raymond James
Nvidia price target raised to $600 from $550 at Raymond James
AMD AMD
$84.00 /

-1.31 (-1.54%)

NVDA Nvidia
$520.03 /

-5.42 (-1.03%)

AMD AMD
$84.00 /

-1.31 (-1.54%)

NVDA Nvidia
$520.03 /

-5.42 (-1.03%)

AMD AMD
$84.00 /

-1.31 (-1.54%)

NVDA Nvidia
$520.03 /

-5.42 (-1.03%)

AMD AMD
$84.00 /

-1.31 (-1.54%)

NVDA Nvidia
$520.03 /

-5.42 (-1.03%)

General news
FX Action: The dollar » 10:15
11/24/20
11/24
10:15
11/24/20
10:15

FX Action: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Action: USD-JPY » 10:15
11/24/20
11/24
10:15
11/24/20
10:15

FX Action: USD-JPY…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
U.S. consumer confidence dropped 5.3 points to 96.1 in November » 10:15
11/24/20
11/24
10:15
11/24/20
10:15

U.S. consumer confidence…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

General news
U.S. Richmond Fed manufacturing index plunged -14 points to 15 in November » 10:15
11/24/20
11/24
10:15
11/24/20
10:15

U.S. Richmond Fed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

Options
FirstEnergy put volume heavy and directionally bearish » 10:15
11/24/20
11/24
10:15
11/24/20
10:15
FE

FirstEnergy

$27.40 /

-0.32 (-1.15%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FE FirstEnergy
$27.40 /

-0.32 (-1.15%)

FE FirstEnergy
$27.40 /

-0.32 (-1.15%)

11/20/20
Fly Intel: Top five analyst downgrades
11/20/20 BofA
FirstEnergy downgraded to Neutral from Buy at BofA
11/18/20 Barclays
FirstEnergy price target raised to $33 from $32 at Barclays
09/17/20 Mizuho
FirstEnergy whistleblower suit reveals SEC investigation, says Mizuho
FE FirstEnergy
$27.40 /

-0.32 (-1.15%)

FE FirstEnergy
$27.40 /

-0.32 (-1.15%)

FE FirstEnergy
$27.40 /

-0.32 (-1.15%)

FE FirstEnergy
$27.40 /

-0.32 (-1.15%)

Conference/Events
MKM Partners analysts to host analyst/industry conference call » 10:14
11/24/20
11/24
10:14
11/24/20
10:14

MKM Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.